Impel Pharmaceuticals Inc.

IMPLNASDAQHealthcare

$0.04

$-0.02(-27.27%)

Market Cap$956000

P/E Ratio—

52W High$4.2

52W Low$0.0212

Avg Volume1.0M

Open$0.05

Beta1.17

Cash on Hand Financials Revenue

Impel Pharmaceuticals Inc. (IMPL) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

IMPL · cash on hand · updated Dec 31, 2022

Core cash position

as of Dec 31, 2022

Cash & Short-Term Investments (CCE + ST Investments)

$60.7M▼ -31.2% vs prior year

FY · as of Dec 31, 2022 · Reported in USD

Cash & Cash Equiv. (CCE)

$60.7M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-31.2%

vs prior fiscal year

Latest Quarter

$239,000

Q3 2023

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2022

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$60.7MCash on Hand

Total Debt$51.2MTotal Debt

Net Cash / Net Debt+$9.5MNet Cash Position

Cash vs Debt Ratio

Cash 54%Impel Pharmaceuticals Inc. cash as % of market cap: 6344.56%% · MCap $0BDebt 46%

Impel Pharmaceuticals Inc. has a net cash position of $9.5M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$60.7M − $51.2M = +$9.5M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

IMPL annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

IMPL cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2022LatestFY$60.7M-31.2%

Dec 31, 2021FY$88.2M+1143.3%

Dec 31, 2020FY$7.1M-80.8%

Dec 31, 2019FY$37.0M—

IMPL cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

IMPL vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Impel Pharmaceuticals Inc.YOU

IMPL

$60.7M$1M6344.6%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Impel Pharmaceuticals Inc. (IMPL) cash on hand as of December 31, 2022 is $60.7M, comprising $60.7M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Impel Pharmaceuticals Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Impel Pharmaceuticals Inc. cash reserves or cash position.

Impel Pharmaceuticals Inc. annual cash on hand history shows decreased -31.2% in 2022: decreased -31.2% in 2022. Impel Pharmaceuticals Inc. cash reserves in 2022 reflect the company's capital allocation strategy.

Impel Pharmaceuticals Inc. carries total debt of $51.2M against cash of $60.7M, resulting in a net cash position of +$9.5M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

IMPL cash on hand · 5 questions

As of December 31, 2022, Impel Pharmaceuticals Inc. (IMPL) has $60,654,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $60,654,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (September 30, 2023): $239,000. Data sourced from the annual 10-K filing via FMP.

IMPL cash on handIMPL cash reservesIMPL cash 2022how much cash does IMPL have

▸ Source: FMP /balance-sheet-statement · US GAAP · Impel Pharmaceuticals Inc. · Impel Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2022